American Healthcare REIT (AHR) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
2 Mar, 2026Portfolio performance and growth
Achieved 11.8% same-store total portfolio NOI growth in Q4 2025, with ISHC/Trilogy at 14.0% and SHOP at 24.6% growth compared to Q4 2024.
Outpatient medical segment reported 92.0% same-store occupancy, and triple-net leased EBITDAR coverage was 1.37x as of September 30, 2025.
Full-year 2026 same-store NOI growth guidance: total portfolio 7.0%-11.0%, ISHC 8.0%-12.0%, SHOP 15.0%-19.0%, outpatient medical 0.0%-2.0%, triple-net leased 2.0%-3.0%.
76.9% of pro-rata cash NOI in Q4 2025 came from managed segments (ISHC & SHOP).
Portfolio includes 319 properties: 147 ISHC, 83 SHOP, 71 outpatient medical, and 18 triple-net leased properties.
Market trends and demand drivers
U.S. population aged 80+ is expected to grow by over 700,000 annually through 2030, while senior housing supply growth remains historically low.
Senior housing development pace is lagging demand, potentially resulting in a $275 billion supply shortfall by 2030.
Construction financing and costs have tightened, further constraining new supply.
Operating model and competitive advantages
ISHC/Trilogy campuses offer a full continuum of care with a mix of senior housing and skilled nursing, averaging 12.6 years in age and 90.1% occupancy.
Trilogy's integrated campus model enables operational efficiencies, high private pay mix, and built-in referral sources.
SHOP segment focuses on needs-based care, with 82% of units in assisted living and memory care, and 90.6% same-store occupancy.
Strong partnerships with high-quality regional operators drive performance and growth.
Latest events from American Healthcare REIT
- Strong demand, limited supply, and integrated care drive robust growth and operational alignment.AHR
Citi’s Miami Global Property CEO Conference 20264 Mar 2026 - Double-digit NOI and NFFO growth in 2025, with strong 2026 guidance and major acquisitions.AHR
Q4 202527 Feb 2026 - Strong Q2 results, raised 2024 guidance, and improved leverage driven by SHOP and ISHC growth.AHR
Q2 20242 Feb 2026 - Strong organic growth and disciplined capital allocation drive value, led by the Trilogy platform.AHR
Nareit REIT Week: 2024 Investor Conference31 Jan 2026 - Q3 2024 saw strong NOI and revenue growth, raised guidance, and improved leverage after key acquisitions.AHR
Q3 202414 Jan 2026 - Strong multi-year growth driven by managed care, Trilogy synergies, and portfolio optimization.AHR
Citi’s 30th Annual Global Property CEO Conference 202523 Dec 2025 - Double-digit NOI and FFO growth in 2024, with strong 2025 guidance and improved leverage.AHR
Q4 202417 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and new equity plan amid strong 2024 results.AHR
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, auditor, compensation, and new stock purchase plan.AHR
Proxy Filing2 Dec 2025